• Latest Posts

Cell Therapy for Heart Failure fails in Phase III … but not Entirely

Cost-effective diagnostics for cancer? Only with VolitionRx!

CAR-T: “This is totally different from what everyone else is doing”

Bone Therapeutics switches to allogeneic for Universal Bone Cell Therapy

EuropaBio: “We as an industry should be proud of what we do”

Llama Antibody Inhalation gets Positive Results for Respiratory Virus

ADVERTISEMENT

Belgian Pediatric Oncology startup Recruits for Brain Tumor Trial

Galapagos and AbbVie expand their Cystic Fibrosis collaboration

Big Pharma invest massively in Biomanufacturing facilities

Anti-ageing DIY Gene Therapy may have worked – to an extent…

Biotech of the Week: Covagen, binding proteins to antibodies for Immunotherapy

Llama Biotech makes €600M deal with AbbVie for Immuno-Oncology

ADVERTISEMENT